{
  "title": "Paper_963",
  "abstract": "Nanomedicine (Lond) Nanomedicine (Lond) 3032 nanomed Nanomedicine 1743-5889 1748-6963 Taylor & Francis PMC11703114 PMC11703114.1 11703114 11703114 39345133 10.1080/17435889.2024.2406218 2406218 1 Version of Record Comment Commentary Optimized strategies for precise messenger RNA delivery using site-specific lipid nanoparticle-based drug delivery systems https://orcid.org/0000-0002-2851-4359 Cao Wei *  a https://orcid.org/0000-0003-0123-1305 Xia Tian **  b a Medical College & Henan Key Laboratory of Cancer Epigenetics The First Affiliated Hospital, School of Clinical Medicine Henan University of Science and Technology Luoyang 471023 China b Department of Medicine University of California Los Angeles CA 90095 USA * caoweiyu@hotmail.com ** Txia@ucla.edu 30 9 2024 2025 20 1 478721 1 4 30 09 2025 30 09 2025 07 01 2025 30 09 2025 Aptara 18 9 2024 30 9 2024 29 7 2024 16 9 2024 Â© 2024 Informa UK Limited, trading as Taylor & Francis Group 2024 Keywords: drug delivery lipid nanoparticle mRNA nanomedicine targeting pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access no pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes ",
  "metadata": {
    "Title of this paper": "Optimized strategies for precise messenger RNA delivery using site-specific lipid nanoparticle-based drug delivery systems",
    "Journal it was published in:": "Nanomedicine",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703114/"
  }
}